Skip to main content
Fig. 10 | BMC Public Health

Fig. 10

From: Geographic variation in the intended choice of adjuvant treatments for women diagnosed with screen-detected breast cancer in Queensland

Fig. 10

Posterior probability of excess chemotherapy-specific spatial effect at SLA level, 1997–2008. Map (a) posterior probability of excess chemotherapy-specific spatial effect (less than 0.2, 0.2–0.8 and greater than 0.8) and a line plot (b) approximate number of ranked SLAs with excess chemotherapy-specific spatial effect in QLD

Back to article page